This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Yu Saruwatari
Introduction
Yu Saruwatari is a notable inventor based in Naruto, Japan. He has made significant contributions to the field of medical infusions, particularly through his innovative patent. His work focuses on improving the stability and effectiveness of infusion preparations.
Latest Patents
Yu Saruwatari holds a patent for a unique infusion preparation. This invention is designed to inhibit the generation of unwanted insoluble matter after mixing two liquids during long-term storage. The infusion preparation consists of two chambers separated by a communicably openable partition. The first chamber contains a fat emulsion along with amino acids that have a buffer action, divalent organic acids, and trivalent organic acids. The second chamber contains an amino acid and calcium as an electrolyte. The total concentration of the amino acids in the first chamber is maintained between 0.15 to 0.5 g/L, ensuring that the mixture has a pH of 6.53 or less when measured 48 hours after the partition is opened.
Career Highlights
Yu Saruwatari is currently employed at Otsuka Pharmaceutical Factory, Inc. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to advancements in pharmaceutical preparations. His work is crucial in enhancing the quality and safety of medical infusions.
Collaborations
Yu has collaborated with notable coworkers, including Seiji Tani and Seiji Fujita. These collaborations have likely contributed to the development and refinement of his innovative infusion preparation.
Conclusion
Yu Saruwatari's contributions to the field of medical infusions exemplify the importance of innovation in healthcare. His patent reflects a commitment to improving patient care through advanced pharmaceutical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
